Pricing Log in Create free account

C4 Therapeutics, Inc. (CCCC) vs Cypherpunk Technologies Inc. (CYPH)

C4 Therapeutics, Inc. and Cypherpunk Technologies Inc. are both Biotechnology companies. C4 Therapeutics, Inc. and Cypherpunk Technologies Inc. are of similar size ($342.0M and $325.5M). C4 Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Cypherpunk Technologies Inc. trades at 4.4×. C4 Therapeutics, Inc. grew revenue faster over the last twelve months: 2.33% against 0.00%. Cypherpunk Technologies Inc. has the higher net margin (0.00% vs −289.4%) and the lower return on invested capital (−8.44% vs 0.00%). Across the 16 metrics below, Cypherpunk Technologies Inc. leads on 10 and C4 Therapeutics, Inc. on 6.

Valuation

Metric CCCC CYPH Biotechnology median
P/E n/m 4.36 8.50
P/S 10.33 315.82 9.71
P/B 1.46 3.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.63 310.73 9.21
Earnings yield (36.10%) 22.96% (33.15%)
Free cash flow yield (23.59%) (4.44%) (25.50%)

Profitability

Metric CCCC CYPH Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (318.97%) 0.00% 0.00%
Net margin (289.44%) 0.00% 0.00%
Free cash flow margin (243.71%) 0.00% 0.00%
Return on equity (48.14%) (1.21%) (56.36%)
Return on assets (30.92%) (1.08%) (48.04%)
Return on invested capital 0.00% (8.44%) 0.00%

Growth

Metric CCCC CYPH Biotechnology median
Revenue growth (TTM) 2.33% 0.00% 6.02%
EPS growth (last fiscal year) 16.45% 103.87% 30.26%
Revenue growth, 5-year CAGR 1.61% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CCCC CYPH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.45 79.19 4.72
Net debt to EBITDA 2.14 0.34 0.96

Dividend

Metric CCCC CYPH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CCCC CYPH Biotechnology median
Market cap 342.01m 325.45m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack